BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,056 filers reported holding BAXTER INTL INC in Q1 2018. The put-call ratio across all filers is 0.59 and the average weighting 0.3%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $215,000 | -17.0% | 3,346 | 0.0% | 0.08% | -4.6% |
| Q1 2022 | $259,000 | -9.8% | 3,346 | 0.0% | 0.09% | -8.4% |
| Q4 2021 | $287,000 | +6.7% | 3,346 | 0.0% | 0.10% | -5.0% |
| Q3 2021 | $269,000 | 0.0% | 3,346 | 0.0% | 0.10% | -2.9% |
| Q2 2021 | $269,000 | -4.6% | 3,346 | 0.0% | 0.10% | -12.7% |
| Q1 2021 | $282,000 | +5.2% | 3,346 | 0.0% | 0.12% | -4.1% |
| Q4 2020 | $268,000 | -0.4% | 3,346 | 0.0% | 0.12% | -10.9% |
| Q3 2020 | $269,000 | -6.6% | 3,346 | 0.0% | 0.14% | -15.9% |
| Q2 2020 | $288,000 | +5.9% | 3,346 | 0.0% | 0.16% | -21.9% |
| Q1 2020 | $272,000 | -2.9% | 3,346 | 0.0% | 0.21% | +19.3% |
| Q4 2019 | $280,000 | -4.4% | 3,346 | 0.0% | 0.18% | -11.6% |
| Q3 2019 | $293,000 | +6.9% | 3,346 | 0.0% | 0.20% | +5.9% |
| Q2 2019 | $274,000 | +0.7% | 3,346 | 0.0% | 0.19% | -1.1% |
| Q1 2019 | $272,000 | +23.6% | 3,346 | 0.0% | 0.19% | +8.0% |
| Q4 2018 | $220,000 | -14.7% | 3,346 | 0.0% | 0.18% | +1.1% |
| Q3 2018 | $258,000 | +4.5% | 3,346 | 0.0% | 0.17% | 0.0% |
| Q2 2018 | $247,000 | +13.3% | 3,346 | 0.0% | 0.17% | +11.5% |
| Q1 2018 | $218,000 | +0.9% | 3,346 | 0.0% | 0.16% | +4.7% |
| Q4 2017 | $216,000 | +2.9% | 3,346 | 0.0% | 0.15% | -3.9% |
| Q3 2017 | $210,000 | +3.4% | 3,346 | 0.0% | 0.16% | +0.6% |
| Q2 2017 | $203,000 | -25.4% | 3,346 | -14.1% | 0.15% | -38.4% |
| Q2 2015 | $272,000 | +1.9% | 3,893 | 0.0% | 0.25% | +2.9% |
| Q1 2015 | $267,000 | +2.7% | 3,893 | +9.8% | 0.24% | +1.2% |
| Q4 2014 | $260,000 | – | 3,546 | – | 0.24% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Third Point | 41,000,000 | $2,482,140,000 | 22.00% |
| THUNDERBIRD PARTNERS LLP | 1,711,643 | $103,623,000 | 12.17% |
| SECTOR GAMMA AS | 1,070,333 | $64,798,000 | 9.42% |
| Veritas Asset Management LLP | 10,179,102 | $616,243,000 | 4.81% |
| 13D Management LLC | 194,807 | $11,794,000 | 4.18% |
| Progressive Investment Management Corp | 78,316 | $4,741,000 | 3.69% |
| Aristotle Capital Management, LLC | 6,846,307 | $414,476,000 | 3.46% |
| ARGENT CAPITAL MANAGEMENT LLC | 1,394,075 | $84,397,000 | 3.37% |
| Lipe & Dalton | 80,073 | $4,848,000 | 3.14% |
| PURA VIDA INVESTMENTS, LLC | 125,000 | $7,568,000 | 3.00% |